DMC Biotechnologies raises $34m in funding round led by Cibus Enterprise

ADM Capital Europe’s Cibus Enterprise, a sustainable food and agriculture fund company, has led a $34 million Series B funding round for US company DMC Biotechnologies. 

The round was also joined by Capricorn Partners, Sofinnova Partners, Breakthrough Energy Ventures, SCG, Boulder Ventures, Solvay Ventures and Michelin.

DMC has developed a technology platform that uses synthetic biology to deliver robust and scalable bioprocesses using microbial fermentation.

This platform produces cost-effective, sustainable ingredients for consumer goods such as precision animal feed, nutrition, personal care and chemical intermediaries.

Alastair Cooper, head of venture investments at The Cibus funds, said: “DMC has a truly unique technology platform which allows for the efficient production of bio-based chemicals that are applicable across a range of industries, most notably the human and animal nutrition markets”.

He continued: “This substantially reduces the economic and environmental costs of production, allowing customers a more resilient and sustainable supply chain. We’re delighted to partner with Matt and his team who have demonstrated exceptional results at commercial scale already, with far less time taken and at a lower cost than traditional biotech approaches.”

Cibus Enterprise is part of The Cibus funds strategy, which focuses on buyout and growth equity opportunities.